Skip to main content
Log in

A novel receptor-targeted gene delivery system for cancer gene therapy

  • Published:
Science in China Series C: Life Sciences Aims and scope Submit manuscript

Abstract

Some growth factor receptors, such as insulin like growth factor I and II receptor (IGF I R, IGF II R) and epidermal growth factor receptor (EGF R), have been proved to be over-expressed in a variety of human cancers derived from different tissue origins. Based on this molecular alteration, a polypeptide conjugate gene delivery system was designed and synthesized. It contains three essential moieties: a ligand oligopeptide (LOP) for receptor recognition, a polycationic polypeptide (PCP) such as protamine (PA) or poly-L-lysine (PL) as a backbone for DNA binding and an endosome-releasing oligopeptide (EROP) such as influenza haemagglutinin oligopeptide (HA20) for endosomolysis. These components are covalently conjugated as LOP-PCP-HA20 or in the form of a mixture of LOP-PCP and HA20-PCP. A 14 amino acid E5 was designed and synthesized as LOP for IGF I R and IGF II R, and a 16 amino acid GE7 as LOP for EGF R. Both E5 and GE7 systems could form stable complex with the plasmid DNA as E5-PCP/ DNA/PCP-HA20 and GE7-PCP/DNA/PCP-HA20. Using bacterial β-galactosidase gene (pSVβ-gal) as a reporter, the present system is able to efficiently target exogenous gene to human cancer cells of different tissue types with high efficiency bothin vitro and in implanted tumors in nude mice. It was also demonstrated that the transduced genes were highly expressed in cancer cells bothin vitro andin vivo. The present system will provide a novel effective vehicle to target therapeutic genes into cancer cells in gene therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Miller, A. D., Law, M. F., Verma, I. M., Generation of helpor-free amphotropic retrovirus that transduce a dominant-action, methotrexate-resistant dihydrofolate reductase gene,Molecular Cellular Biology, 1985, 5: 431.

    CAS  Google Scholar 

  2. McDonald, R. J., Lnkason, M. J., Raobe, O. G. et al., Safety of airway gene transfer with Ad2/CFTR2: Aersol adminis-tration in the nonhuman primate,Human Gene Therapy, 1997, 8: 411.

    Article  PubMed  CAS  Google Scholar 

  3. Walther, F. J., Uptake of antioxidants in surfactant liposomes is enhanced by SP-A,American J. Physiol., 1993, 265: 1330.

    Google Scholar 

  4. Wu, G. Y., Wu, C. H., Receptor-mediatedin vitro gene transformation by a soluble DNA carrier system,J. Biol. Chem., 1987, 262: 4429.

    PubMed  CAS  Google Scholar 

  5. Wu, C. H., Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elementsin vivo, J. Bio. Chem., 1989, 264: 19685.

    Google Scholar 

  6. Cotton, M., Langle-Rouault, F., Kirlappos, H. et al., Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels,PNAS, 1990, 87: 4033.

    Article  Google Scholar 

  7. Midar, P., Mendes, C., Legrand, A. et al., Specific gene transfer mediated by lactotated poly-L-lysine into hepatoma cells,Nuc. Aci. Res., 1993, 21: 871.

    Article  Google Scholar 

  8. Zhou, X. M., Gu, J. R., David, S. et al., Stimultaneous overexpression of insulin-like growth factor II (IGF II) and IGF II receptor genes in human primary hepatic cancer,Tumour (in Chinese), 1991, 11: 241.

    Google Scholar 

  9. Wrann, M. M., Fox, C. F., Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line,J. Biol. Chem., 1979, 254: 8083.

    PubMed  CAS  Google Scholar 

  10. Carlsson, B. J., Drevin, H., Axen, R., Protein thiolation and reversible protein-protein conjugation,Biochem. J., 1978, 173: 723.

    PubMed  CAS  Google Scholar 

  11. Stuchbury, T., Shipton, M., Norris, R. et al., A receptor group delivery system with both absolute and selective specificity for thiol groups and improved fluorescent probe centaining the 7-nitrobenzo-2-oxa-l, 3-diazole moiety,Biochem. J., 1975, 151: 417.

    PubMed  CAS  Google Scholar 

  12. Xu, L., Pirollo, K. F., Chang, E. H., Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiationin vitro, Human Gene Therapy, 1997, 8: 467.

    Article  PubMed  CAS  Google Scholar 

  13. Cristiano, R. J., Roth, J. A., Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor,Cancer Gene Therapy, 1996, 3(1): 4.

    PubMed  CAS  Google Scholar 

  14. Wade, J., CDK inhibitors in development and cancer,Current Opinion in Genetics &Development, 1996, 6: 56.

    Article  Google Scholar 

  15. Ren, C. C., Tian, P. K., Qu, S. M. et al., Expression of cyclin-dependent kinase inhibitor genes induces apoptosis in human hepatoma cell line,Chinese Science Bulletin, 1997, 42(23): 2000.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Project supported by the Biotechnology Project, National High Technology Program and Shanghai Municipal Science and Technology Program.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tian, P., Ren, S., Ren, C. et al. A novel receptor-targeted gene delivery system for cancer gene therapy. Sci. China Ser. C.-Life Sci. 42, 216–224 (1999). https://doi.org/10.1007/BF02880059

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02880059

Keywords

Navigation